This study analyzed the diagnostic value of PER3 in GBM by selecting two molecular pathology indicators of GBM from the Glioma Diagnostic and Treatment Guidelines and analyzing the ROC curves together with PER3 as a diagnostic factor. This evidence concerns the gene PER3 and central nervous system cancer.